REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
Sponsored by Medtronic Cardiovascular
About this study
The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).
Primary Objectives: * To determine the acute and long-term outcomes of redo TAVR for the treatment of BVF affecting TAVs * To determine the factors which are associated with the acute and long-term outcomes of redo TAVR
Where this study is enrolling
- Call 713.790.3311
Houston Methodist Hospital
Houston, Texas
This research site can be reached directly by phone. Call to ask about this study.
Create a free account to get updates on similar Clinical Trials for your conditions.
Who can participate
Inclusion criteria
- ✓BVF of a TAV (either Medtronic or Edwards) requiring redo TAVR
Exclusion criteria
- ✕BVF due solely to paravalvular regurgitation
- ✕Active endocarditis
- ✕Untreated acute valve thrombosis
- ✕Life-expectancy less than 1-year
- ✕Subject is less than legal age of consent, legally incompetent, or otherwise vulnerable
- ✕Participating in another study that may influence the outcome of this study
Only the research team can confirm whether you qualify. The intake questionnaire is the best way to find out.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.